Co-founder and CEO Dave Suchon told BNN Bloomberg the company intends to develop and manufacture domestically: Were going to be making it here in Canada Weve done our research and development here in Canada as well. The company says, the potential is phenomenal. Novo Nordisks semaglutide products Ozempic and Wegovy have been blockbuster sensations as millions of people have sought them to treat type 2 diabetes, weight loss, obesity and other health conditions
There was no role of the funding body in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared
Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, et al
A Multi-Faceted Ally in Recovery For those living with chronic Lyme disease, where pain, fatigue, and immune chaos dominate daily life, BPC-157 represents a multi-layered therapeutic option
Easy and Affordable